INTRODUCTION
Infection of human immunodeficiency virus-1 (HIV-1) induces extensive neuro-inflammation that may contribute to various neurologic dysfunctions, such as HIV-associated encephalitis and dementia. The entry of immune cells including monocytes and T lymphocytes into the central nervous system (CNS) is a characteristic feature of HIV-1-mediated neuro-inflammation (1) . CNS infiltration of immune cells is enhanced by several pro-inflammatory mediators including chemokines (2) .
HIV-1 trans-activator of transcription (Tat) can up-regulate the expression of various chemokines including CCL2, CXCL8, and CXCL10, in astrocytes (3, 4) . Up-regulation of these chemokines facilitates the entry of immune cells in the CNS (5) . Therefore, HIV-1 Tat is considered to be an important viral protein involved in the development of neuro-inflammation (6) .
HIV-1 Tat stimulates several intracellular signaling cascades that then activate transcription factors, resulting in production of pro-inflammatory chemokines. A previous study showed that activation of astrocytes with HIV-1 Tat up-regulated expression of histone deacetylase 6 (HDAC6) (7) . Pharmacological and genetic studies revealed that HDAC6 mediated HIV-1 Tat-mediated production of the chemokines CCL2, CXCL8, and CXCL10 in astrocytes (7) , indicating that HDAC6 is main regulator of HIV-1 Tat-induced production of inflammatory mediators. HIV-1 Tat also activates Nox2-based NADPH oxidase that generates reactive oxygen species (ROS), contributing to the production of pro-inflammatory chemokines (8) . NADPH oxidase contains membrane-bound components (Nox2/gp91 phox and p22 phox ) and cytosolic components (small GTPase Rac, p40 phox , p47 phox , p67 phox ) (9) . We recently demonstrated that regulatory crosstalk between HDAC6 and NADPH oxidase mediated HIV-1 Tat-induced chemokine production (8) . In addition, HIV-1 Tat activates redox-sensitive transcription factors including nuclear factor kappa B (NF-B) and activator protein-1 (AP-1) that contribute to the production of inflammatory mediators (10) (11) (12) .
Hindsiipropane B, a 1,3-diarylpropane, present in Celastrus hindsii, is one of the bioactive compounds that have been used as traditional Chinese medicine (13) . Previous studies have reported that hindsiipropane B and 1,3-diarylpropane analogs exert protective effects on lipopolysaccharide-mediated inflammatory responses in macrophages (14, 15) . Based on its immunomodulatory activity, this study explored the regulatory http://bmbreports.org BMB Reports roles of hindsiipropane B in HIV-1 Tat-mediated proinflammatory responses and its action modes in astrocytes.
In the present study, we show that hindsiipropane B ameliorated production of CCL2, CXCL8 and CXCL10 by blocking the HDAC6-NADPH oxidase-MAPK-NF-B/AP-1 signaling axis in astrocytes stimulated with HIV-1 Tat. These results suggest that hindsiipropane B could be a therapeutic candidate against HIV-1 Tat-mediated neuro-inflammation.
RESULTS
Hindsiipropane B inhibits chemokine production in HIV-1 Tat-stimulated astrocytes Extracellular HIV-1 Tat has been shown to up-regulate chemokines, such as CCL2, CXCL8, and CXCL10, in astrocytes (3, 4, 7) . To investigate the regulatory effect of hindsiipropane B (Fig. 1A) on HIV-1 Tat-mediated chemokine production, CRT-MG human astroglial cells were incubated with hindsiipropane B at concentrations of 2-10 M for 1 h and then followed by stimulation with 50 nM HIV-1 Tat. Hindsiipropane B did not show any cytotoxicity at the concentrations up to 15 M (data not shown). We measured the levels of chemokine mRNA and protein by RT-qPCR and ELISA, respectively. Hindsiipropane B dose-dependently decreased the amounts of CCL2, CXCL8 and CXCL10 mRNA in HIV-1 Tat-treated CRT-MG cells (Fig. 1B) . We also observed that hindsiipropane B decreased the amounts of CCL2, CXCL8 and CXCL10 proteins in the culture solution of both cells stimulated by HIV-1 Tat (Fig. 1C) .
Hindsiipropane B inhibits HDAC6 expression and MAPK activation in HIV-1 Tat-stimulated astrocytes HDAC6 expression and MAPK activation have been shown to be crucial for HIV-1 Tat-mediated production of inflammatory chemokines in astrocytes (7) . Therefore, we examined the effect of hindsiipropane B on HIV-1 Tat-mediated HDAC6 expression in astrocytes. Hindsiipropane B dose-dependently suppressed HIV-1 Tat-induced mRNA and protein expression of HDAC6 in CRT-MG cells ( Fig. 2A and B) . Decreased HDAC6 expression was correlated with increased acetylated -tubulin in cells (Fig. 2B) .
We next examined the effects of hindsiipropane B on activated ERK, JNK and p38 MAPK in HIV-1 Tat-stimulated astrocytes. HIV-1 Tat increased the phosphorylation levels of ERK, JNK, and p38 MAP kinase ( Cells were pretreated with hindsiipropane B for 1 h and then stimulated with 50 nM HIV-1 Tat for 1 h. Cells were stained with DHE for 30 min. The levels of intracellular ROS probed with DHE were evaluated using an ELISA plate reader. (B) Cells pretreated with hindsiipropane B for 1 h were exposed to 50 nM HIV-1 Tat for 1 h. Cells were collected and mixed with 250 M NADPH. NADPH depletion was observed by measuring reduction in absorbance at  = 340 for 10 min. (C) Cells pretreated with hindsiipropane B for 1 h were exposed to 50 nM HIV-1 Tat for 1 h. Cell lysates were collected and immune-precipitated with gp91phox/NOX2 antibody, followed by Western blotting using a p47phox antibody to determine the levels of p47phox associated with gp91phox/NOX2. (D) Cells pretreated with hindsiipropane B for 1 h were stimulated with 50 nM HIV-1 Tat for 3 h. Total RNA was collected and assayed for mRNA levels of gp91phox/NOX2, p47phox, p22phox, and -actin by quantitative RT-PCR. Data are shown as mean ± SD of three independent experiments. *P ＜ 0.05, **P ＜ 0.01, ***P ＜ 0.001, 
Hindsiipropane B inhibits HIV-1 Tat-mediated NADPH oxidase activation and ROS generation in astrocytes
Since Nox2-based NADPH oxidase is a critical enzyme complex for HIV-1 Tat-mediated ROS generation responsible for up-regulation of pro-inflammatory factors in astrocytes (12), we analyzed the effects of hindsiipropane B on HIV-1 Tat-mediated ROS generation and NADPH oxidase activation in astrocytes. Hindsiipropane B reduced HIV-1 Tat-induced ROS generation, as judged by DHE staining (Fig. 3A) . We then evaluated the effect of hindsiipropane B on HIV-1 Tat-mediated NADPH oxidase activity and found that it significantly suppressed this activity (Fig. 3B) . In addition, hindsiipropane B decreased the level of p47 phox associated with gp91 phox /Nox2 in a co-immunoprecipitation experiment (Fig. 3C) . We further analyzed the effect of hindsiipropane B on HIV Tat-mediated expression of NADPH oxidase subunits. Hindsiipropane B dose-dependently decreased HIV-1 Tat-induced mRNA expression of gp91 phox /Nox2, p47 phox and p22 phox (Fig. 3D ).
Hindsiipropane B inhibits HIV-1 Tat-mediated activation of NF-B and AP-1 in astrocytes
Both NF-B and AP-1 signaling cascades contribute to the production of pro-inflammatory chemokines on stimulation with HIV-1 Tat (4, 10-12). We examined the effects of hindsiipropane B on the signaling cascades responsible for NF-B and AP-1 activation. Hindsiipropane B reduced NF-B p65 phosphorylation and restored IB degradation in HIV-1 Tat-treated cells (Fig. 4A) . We also observed that hindsiipropane B decreased p65 translocation into the nucleus in HIV-1 Tat-stimulated cells (Fig. 4A) . Similarly, hindsiipropane B alleviated HIV-1 Tat-mediated c-Jun phosphorylation as well as c-jun/c-fos translocation into the nucleus (Fig. 4C) . We next evaluated the effect of hindsiipropane B on DNA binding activity of NF-B and AP-1 subunit using EMSA. Hindsiipropane B reduced HIV-1 Tat-mediated NF-B and AP-1 DNA binding activities ( Fig. 4B and D) .
DISCUSSION
The recruitment and retention of immune cells into the CNS, an important step in neuro-inflammation, are regulated by various pro-inflammatory mediators including adhesion molecules, cytokines and chemokines. Therefore, proinflammatory mediator inhibition in the CNS may be a target in screening therapeutic compounds against neuro-http://bmbreports.org BMB Reports inflammation. Hindsiipropane B, a 1,3-diarylpropane, has been shown to down-regulate expression of inflammatory factors, such as COX-2 and iNOS, by suppressing MAPK and NF-B signaling cascades (14, 15) . However, the action modes by which hindsiipropane B exerts anti-inflammatory activity
have not yet elucidated. In this study, we demonstrated that hindsiipropane B ameliorated HIV-1 Tat-induced CCL2, CXCL8 and CXCL10 expression by suppressing the HDAC6-NADPH oxidase-ROS-MAPK-NF-kB/AP-1 axis in astrocytes. Astrocytes are major players in mediating the inflammatory process by expressing various pro-inflammatory chemokines that regulate the recruitment and retention of immune cells into the CNS. HIV-1 Tat induces abnormal expression of various chemokines, such as CCL2, CXCL8, and CXCL10, that may facilitate the pathologic process during HIV-related neurological disorder (16, 17) . Hindsiipropane B significantly suppressed HIV-1 Tat-mediated production of CCL2, CXCL8, and CXCL10 by decreasing their mRNA levels in CRT-MG cells and mouse primary astrocytes (data not shown), indicating its anti-inflammatory activity in HIV-1 Tat-treated astrocytes.
HDAC6 expression has been shown to be a key player in production of pro-inflammatory mediators including chemokines (7, 18) . Consequently, HDAC6 is considered to be a pivotal target in HIV-1 Tat-mediated neuro-inflammation. Our previous studies elucidated that HIV-1 Tat enhanced HDAC6 expression that was critical for HIV-1 Tat-induced production of CCL2, CXCL8, and CXCL10 in astrocytes (7, 8) and the contribution of HDAC6 to HIV-1 Tat-mediated production of pro-inflammatory chemokines was confirmed by genetic and pharmacological studies (7) . Recent experiments using overexpression of HDAC6 demonstrated the involvement of HDAC6 in pro-inflammatory cytokine expression in macrophages (18) . Consistent with these results, hindsiipropane B suppressed HIV-1 Tat-induced HDAC6 expression, concomitant with increased acetylated -tubulin in astrocytes. These results indicate that hindsiipropane B down-regulates CCL2, CXCL8, and CXCL10 expression by suppressing HDAC6 expression in astrocytes.
NADPH oxidase-derived ROS participates in activating various signal transduction processes in astrocytes (19) (20) (21) . HIV-1 Tat has been demonstrated to be capable of activating Nox2-based NADPH oxidase, leading to ROS generation that is responsible for pro-inflammatory chemokine expression (8, 12) . In addition, HIV-1 Tat increases the expression of NADPH oxidase subunits, such as gp91 Stimulating astrocytes with HIV-1 Tat initiates activation of MAPK signaling cascades in which ERK, JNK, and p38 are phosphorylated, and they participate in the production of pro-inflammatory mediators (22, 23) ; hindsiipropane B decreased HIV-1 Tat-mediated activation of all three MAPKs. Although the exact roles of the different MAPKs have not been explored in HIV-1 Tat-mediated pro-inflammatory chemokine expression, all three MAPKs participate in NF-B activation in HIV-1 Tat-stimulated human astrocytes (4, 10) . JNK is known to contribute to AP-1 activation in astrocytes.
Because activation of NF-B and/or AP-1 contributes to HIV-1 Tat-mediated chemokine expression (10, 12), we next performed experiments to evaluate the effects of hindsiipropane B on NF-B and AP-1 signaling cascades. Hindsiipropane B suppressed the NF-B signaling axis including IKK phosphorylation, IB degradation and p65 phosphorylation/nuclear localization in HIV-1 Tat-treated astrocytes. A previous study suggested that hindsiipropane B exerted its anti-inflammatory effects by down-regulating LPS-induced NF-B activation (15) . Consistent with these results, hindsiipropane B inhibited NF-B activation in HIV-1 Tat-stimulated cells. Hindsiipropane B also diminished HIV-1 Tat-mediated c-jun phosphorylation, c-jun/c-fos nuclear localization, and AP-1 promoter activity. These results collectively point out that hindsiipropane B exerts its anti-inflammatory effects by inhibiting MAPK-NF-B/AP-1 signaling axis in HIV-1 Tat-treated astrocytes.
In conclusion, our study provide evidences that hindsiipropane B exerts suppressive activity on production of pro-inflammatory chemokines, such as CCL2, CXCL8, and CXCL10, in HIV-1 Tat-treated astrocytes. This anti-inflammatory activity is mediated by suppressing HDAC6-NADPH oxidase-ROS-MAPK-NF-B/AP-1 axis in astrocytes. Elucidating the action mechanisms by which hindsiipropane B down-regulates pro-inflammatory mediators may lead to developing therapeutic agents against HIV-1 Tat-related neuro-inflammation.
MATERIALS AND METHODS

Reagents
Primary antibodies against gp91phox/NOX2, p47phox, acetylated -tubulin, p65, IkB, c-fos, and c-jun were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Total-ERK, total-p38, total-JNK, phosphor-ERK, phosphor-p38, phosphor-JNK, -actin, and HDAC6 were purchased from Cell Signaling Technology (Beverly, MA, U.S.A.). Hindsiipropane B was synthesized from commercially available starting materials with the Wittig-Horner reaction, Claisen-Schmidt condensation and hydrogenation as key steps (14) . 10 mM stock solution of hindsiipropane B was prepared in dimethyl sulfoxide.
Oligonucleotide primers (HDAC6, CCL2, CXCL8, CXCL10, Nox2, p22phox, p47phox, and -actin) (Bioneer, Seoul, Korea) were obtained from commercially.
Cell culture
An human astroglial cell line CRT-MG was grown in RPMI 1640 medium containing 10% fetal bovine serum, L-glutamine (2 mM), streptomycin (100 g/ml), and penicillin G (100 U/ml) at 37 o C in a humidified air supplemented with 5% CO2 (24) .
Preparation of HIV-1 Tat Protein
Glutathione S-transferase (GST)-Tat fusion protein was expressed from the GST-Tat 1 86R plasmid obtained from the National Institutes of Health AIDS Research and Reference Reagent Program (Rockville, MD, USA). Purified GST-Tat fusion protein was digested with thrombin to get HIV-1 Tat protein as described previously (25) . The endotoxin amount in the HIV-1 Tat preparation were below 0.3 EU/ml as determined by a Limulus Amoebocyte Lysate assay (BioWhitaker, Walkersville, MD, USA).
Western blot analysis
Cells were lysed using a buffer containing 125 mM Tris-HCl pH 6.8, 2% SDS, 10% v/v glycerol. The protein concentrations of the cell lysates were assessed by Bradford protein assay (Bio-Rad, Hercules, CA, USA). Thirty micrograms of proteins were separated on 10% SDS-PAGE, and transferred to nitrocellulose membranes. The blots were probed with the primary antibody against the target protein at 4 o C overnight, followed by incubation with the horseradish peroxidase (HRP)-conjugated secondary antibody (1:10,000 dilution) for 2 h at room temperature. The antibody-reactive bands were visualized by a chemiluminescence kit (Amersham Life Sciences, Parsippany, NJ, USA) (26).
Real-time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) analysis
Total cellular RNA was prepared using a Trizol reagent kit (Invirogen, Gaithersburg, MD, USA). Two micrograms of total RNA were reverse-transcribed into cDNA using 10,000 U of reverse transcriptase and 0.5 g/l oligo-(dT)15 primer (Promega) (8) . The resulting cDNA was analyzed by quantitative PCR using iQ TM SYBR Ⓡ Green Supermix (BIO-RAD, Hercules, CA, USA) with the primer sets described previously (8) .
Enzyme-Linked Immunosorbent Assay (ELISA)
Culture media were harvested and analyzed for the levels of chemokines (CCL2, CXCL8, and CXCL10) by ELISA kits (R&D Systems, Minneapolis, MN, USA), according to the manufacturer's instructions.
Assessment of Intracellular ROS Generation
Intracellular ROS levels were determined by a dihydroethidium (DHE) assay as described previously (8) . DHE is converted by superoxide into red fluorescent ethidium. The intensity of cellular fluorescence for DHE was determined at 590 nm excitation and 650 nm emission using a SpectraMax M2 ELISA plate reader (Molecular Devices, Sunnyvale, CA, USA).
Measurement of NADPH Oxidase Activity
Cells collected from 6 wells-plates were re-suspended in phosphate buffered saline. The enzymatic activity of NADPH oxidase in the samples was determined as described previously (12) .
Detection of p47
phox Association with gp91 phox
The levels of p47 phox associated with gp91 phox were assessed by co-immunoprecipitation followed by Western blot analysis as described previously (8) . Briefly, cells were incubated with a lysis buffer consisting of 50 mM HEPES (pH 7.5), 150 mM NaCl, 2 mM EDTA, 0.5% NP-40, 5% glycerol, and complete mini protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN, USA). The clarified cellular lysates were reacted with anti-gp91 phox antibody at 4 o C overnight on a rotating shaker. Immune complexes were collected by protein A/G-agarose beads (Santa Cruz Biotechnology, Dallas, TX, USA). Aliquots of immune-precipitates were separated on 10% SDS-PAGE and analyzed by Western blotting using an anti-p47 phox antibody described above.
Electrophoretic Mobility Shift Assay (EMSA)
Cells were pretreated with hindsiipropane B for 1 h, followed by stimulation with HIV-1 Tat (50 nM) for 1 h. Nuclear extracts of cells were analyzed for NF-B or AP-1 binding activity by EMSA as described previously (27) .
Statistical analysis
Results are presented as the mean ± standard deviation (SD) from three independent experiments. Statistical analysis was performed by one-way analysis of variance, followed by Bonferroni's test using SigmaPlot 10.0 software (SYSTAT Software Inc, Chicago, IL, USA). Differences were considered significant at P ＜ 0.05.
